Paxlovid Kit
Product Images NDC 0069-5045

32 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Paxlovid (NDC 0069-5045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Paxlovid 01)

Chemical Structure (Paxlovid 01)
Chemical structure of the active ingredient nirmatrelvir, part of the Paxlovid kit. The diagram shows molecular bonds, various functional groups including fluorines, and stereochemistry marked with (S) and (R) configurations.*
FDA Label Image

Chemical Structure (Paxlovid 02)

Chemical Structure (Paxlovid 02)
Chemical structure of nirmatrelvir, the active ingredient in Paxlovid, showing its molecular formula with various functional groups including amide and thiazole rings.*
FDA Label Image

Figure 1 (Paxlovid 03)

Figure 1 (Paxlovid 03)
A horizontal forest plot showing the percentage difference in efficacy between Nirmatrelvir 300 mg plus Ritonavir 100 mg and placebo across various patient categories. The categories include symptom onset duration, age, gender, BMI, diabetes status, hypertension status, baseline SARS-CoV-2 serology status, baseline nasopharyngeal viral RNA levels, and COVID-19 mAb treatment. The plot illustrates confidence intervals for each category's effect size relative to placebo.*
FDA Label Image

Pfizer (Paxlovid 04)

FDA Label Image

Figure A (Paxlovid 05)

Figure A (Paxlovid 05)
Paxlovid kit by Pfizer Laboratories, containing nirmatrelvir tablets (300 mg) and ritonavir tablets (100 mg) co-packaged for oral use. The label provides dosing instructions to take all 3 tablets together twice daily for 5 days and includes a warning not to cover the ALERT box with pharmacy labels.*
FDA Label Image

Figure A1 (Paxlovid 06)

Figure A1 (Paxlovid 06)
An illustration diagram for Paxlovid showing the three tablets to be taken together: two nirmatrelvir tablets (150 mg each) and one ritonavir tablet (100 mg). This visual explains the co-packaged oral use dosage of 300 mg nirmatrelvir and 100 mg ritonavir under prescription use.*
FDA Label Image

Figure A2 (Paxlovid 07)

Figure A2 (Paxlovid 07)
Three oral tablets are shown, two pink and one white. One pink tablet is oval and unmarked, the other pink tablet is oval and imprinted with '30' and 'PFE'. The white tablet is oblong and unmarked. The image corresponds to Paxlovid, a human prescription drug kit containing nirmatrelvir and ritonavir tablets, labeled by Pfizer Laboratories Div Pfizer Inc.*
FDA Label Image

Figure A3 (Paxlovid 07a)

Figure A3 (Paxlovid 07a)
An instructional diagram for Paxlovid tablets showing three tablets to be taken together: two nirmatrelvir tablets labeled 150 mg each and one ritonavir tablet labeled 100 mg. Arrows indicate the grouping of these tablets for co-administration.*
FDA Label Image

Figure A4 (Paxlovid 07b)

Figure A4 (Paxlovid 07b)
The image shows three oral tablets representing the antiviral medication Paxlovid by Pfizer Laboratories Div Pfizer Inc. It includes two oblong, pink tablets and one round, white tablet, typical of the combination medication's multiple tablet dosing form.*
FDA Label Image

Figure B (Paxlovid 08)

Figure B (Paxlovid 08)
Paxlovid kit packaging label by Pfizer Laboratories Div Pfizer Inc. It contains nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg) co-packaged for oral use in a dose pack. The label includes dosing instructions to take both tablets together twice daily for 5 days, with a caution to not cover alert box on the pharmacy label and a note not to alter other medicines without consulting a healthcare provider.*
FDA Label Image

Figure B1 (Paxlovid 09)

Figure B1 (Paxlovid 09)
Paxlovid kit label displaying nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg). The label indicates these two tablets are co-packaged for oral use and should be taken together. The labeler is Pfizer Laboratories Div Pfizer Inc. The packaging includes a pink background and mentions 'Rx only.'*
FDA Label Image

Figure B2 (Paxlovid 09a)

Figure B2 (Paxlovid 09a)
Image of two tablets for Paxlovid by Pfizer Laboratories Div Pfizer Inc. One tablet is white, round, and embossed with the letters 'PFE'. The other tablet is pink, oblong, and does not display visible markings in this image.*
FDA Label Image

Figure B3 (Paxlovid 09b)

Figure B3 (Paxlovid 09b)
Paxlovid co-packaged tablets label showing nirmatrelvir 150 mg tablets and ritonavir 100 mg tablets. The label instructs to take these two tablets together and notes cavities intentionally left empty in the packaging. Manufactured by Pfizer Laboratories Div Pfizer Inc.*
FDA Label Image

Figure B4 (Paxlovid 09c)

Figure B4 (Paxlovid 09c)
Two tablets of Paxlovid by Pfizer Laboratories Div Pfizer Inc are shown. One tablet is white and oval-shaped, and the other is pink and oval-shaped with the imprint "PFE" visible on it. No further text or dosage details are visible in the image.*
FDA Label Image

Figure C (Paxlovid 10)

Figure C (Paxlovid 10)
Image of two oblong tablets from the Paxlovid kit, a human prescription drug by Pfizer Laboratories Div Pfizer Inc. One tablet is pink with "PFIZER" imprinted, and the other is plain white. These represent the nirmatrelvir and ritonavir components in tablet form.*
FDA Label Image

Image (Paxlovid 10a)

Image (Paxlovid 10a)
Paxlovid medication label showing dosing instructions for Day 1 with a total dose of 300 mg nirmatrelvir and 100 mg ritonavir. The label indicates co-packaging of nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg each) for oral use, with a direction to take three tablets together on the first day. The product is labeled by Pfizer Laboratories Div Pfizer Inc and marked Rx only.*
FDA Label Image

Figure C2 (Paxlovid 10b)

Figure C2 (Paxlovid 10b)
Image of three Paxlovid tablets from Pfizer Laboratories. Two tablets are pink, rectangular with rounded edges and scored, each marked with 'PFE', and one tablet is white, oval-shaped, unmarked. No strength or dosage form information is visible on the tablets.*
FDA Label Image

Image (Paxlovid 10ab)

Image (Paxlovid 10ab)
An instructional diagram showing the dosing schedule for Paxlovid tablets over Days 2 to 5. Each day, it instructs to take two tablets together: one nirmatrelvir 150 mg tablet and one ritonavir 100 mg tablet. The layout emphasizes the pairing of these tablets daily during the treatment period.*
FDA Label Image

Figure C3 (Paxlovid 10c)

Figure C3 (Paxlovid 10c)
Image of two Paxlovid tablets. One oblong white tablet and one elliptical pink tablet imprinted with "PFE". The image shows the tablets without any packaging or additional labeling.*
FDA Label Image

Logo (Paxlovid 11)

FDA Label Image

Principal Display Panel (3 Tablet Blister Pack)

Principal Display Panel (3 Tablet Blister Pack)
The label for Paxlovid kit, containing nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg), co-packaged for oral use. It instructs to take three tablets together, consisting of two nirmatrelvir tablets and one ritonavir tablet. Distributor is Pfizer Labs, Div. of Pfizer Inc, NY.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Paxlovid 300 mg; 100 mg Dose Pack packaging label for a human prescription drug kit by Pfizer Laboratories Div Pfizer Inc. The label shows Paxlovid co-packaged tablets of nirmatrelvir and ritonavir for oral use, instructions for dosage (three tablets from one blister card twice daily for 5 days), storage conditions, lot information, barcode, and a QR code for additional prescribing information.*
FDA Label Image

Principal Display Panel (3 Tablet Blister Pack)

Principal Display Panel (3 Tablet Blister Pack)
Label for Paxlovid kit containing nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg), co-packaged for oral use. The label instructs to take three tablets together: two nirmatrelvir tablets and one ritonavir tablet. Distributed by Pfizer Laboratories Div Pfizer Inc.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Paxlovid 300 mg / 100 mg Dose Pack kit packaging label for oral use tablets containing nirmatrelvir and ritonavir. The label states co-packaged tablets with dosing instructions to take all 3 tablets from one blister card twice daily for 5 days. The label shows Pfizer Laboratories Div Pfizer Inc as the labeler, includes a barcode, storage and dispensing information, and manufacturing details.*
FDA Label Image

Principal Display Panel (2 Tablet Blister Pack)

Principal Display Panel (2 Tablet Blister Pack)
Paxlovid kit label showing nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg) co-packaged for oral use. The label includes dosage strengths, a barcode, lot and expiration fields, and notes that the kit is Rx only, distributed by Pfizer Laboratories Division of Pfizer Inc.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for Paxlovid kit containing nirmatrelvir and ritonavir tablets in a 150 mg/100 mg dose pack. The label features dosage instructions to take both tablets from one blister card twice daily for 5 days. Manufactured by Pfizer Laboratories Div Pfizer Inc, the label includes barcodes, a QR code, and storage information.*
FDA Label Image

Principal Display Panel (11 Tablet Blister Pack)

Principal Display Panel (11 Tablet Blister Pack)
Paxlovid dosing instructions graphic showing tablet amounts for days 1 through 5. Day 1 directs taking three tablets together: two nirmatrelvir 150 mg tablets and one ritonavir 100 mg tablet. Days 2 to 5 direct taking two tablets together: one nirmatrelvir 150 mg tablet and one ritonavir 100 mg tablet each day. The image includes the NDC 0069-0521-11 and identifies Pfizer Laboratories Div Pfizer Inc as the distributor.*
FDA Label Image

Principal Display Panel – Kit Carton (0069-0521)

Principal Display Panel – Kit Carton (0069-0521)
Paxlovid packaging label for co-packaged nirmatrelvir and ritonavir tablets. Strengths indicated are 300 mg and 100 mg for Day 1, and 150 mg and 100 mg for Days 2 to 5. The label includes dosage instructions, storage conditions, manufacturer Pfizer Laboratories Div Pfizer Inc, and distribution information. It also features barcodes and a QR code for additional information.*
FDA Label Image

Principal Display Panel (2 Tablet Blister Pack)

Principal Display Panel (2 Tablet Blister Pack)
Packaging label for Paxlovid tablets by Pfizer Laboratories Div Pfizer Inc, indicating co-packaged nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg). Instructions on the label emphasize taking the two tablets together. The label is pink and includes an NDC code and a barcode with distribution information.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Paxlovid 150 mg / 100 mg Dose Pack packaging label showing nirmatrelvir and ritonavir tablets co-packaged for oral use. The label includes directions for use, dose pack details, storage instructions, barcode, QR code, and manufacturer information from Pfizer Laboratories Div Pfizer Inc.*
FDA Label Image

Principal Display Panel (11 Tablet Blister Pack)

Principal Display Panel (11 Tablet Blister Pack)
Directions for Paxlovid (nirmatrelvir tablets; ritonavir tablets) packaging showing a 5-day dosing schedule. Day 1 includes a dose of 300 mg nirmatrelvir (two 150 mg tablets) and 100 mg ritonavir (one tablet), taken together as 3 tablets. Days 2 to 5 show doses of 150 mg nirmatrelvir (one tablet) and 100 mg ritonavir (one tablet), taken together as 2 tablets daily. The image also includes the NDC number, barcode, and manufacturer details for Pfizer Laboratories.*
FDA Label Image

Principal Display Panel – Kit Carton (0069-5450)

Principal Display Panel – Kit Carton (0069-5450)
Packaging label of Paxlovid co-packaged oral use tablets by Pfizer Laboratories Div Pfizer Inc. It features dosage strengths of 300 mg (Day 1) and 150 mg (Days 2-5). The label includes dosing instructions, storage conditions, and prescriber information. The design has an orange and pink color scheme with Pfizer logos and barcodes visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.